Epigenetic silencing of miRNA-338-5p and miRNA-421 drives SPINK1-positive prostate cancer
Vipul Bhatia(Fred Hutch Cancer Center), Bushra Ateeq(Indian Institute of Technology Kanpur), Anjali Yadav(Indian Institute of Technology Kanpur), Shivansh Nigam(Indian Institute of Technology Kanpur), Nallasivam Palanisamy(Henry Ford Health System), Sakshi Goel(Molecular Oncology (United States)), Apul Goel(King George's Medical University), Nilesh Gupta(Henry Ford Health System), Shannon Carskadon(Henry Ford Health System), Ritika Tiwari(Rajasthan University of Veterinary and Animal Sciences)
Cited by 10
Related Papers
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
|Cancer Discovery|2013|737
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth
|JAMA|2015|420
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
|Clinical Cancer Research|2013|358
Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma
|Modern Pathology|2014|227
ERG gene rearrangements are common in prostatic small cell carcinomas
|Modern Pathology|2011|219